المؤلفون: Norling B; University of Minnesota School of Medicine, Minneapolis, Minnesota., Jung JH; Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.; Center of Evidence Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Republic of Korea., Hwang EC; Department of Urology, Chonnam National University Medical School, Hwasun, Republic of Korea., Han MA; Department of Preventive Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea., Khaleel S; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Schünemann HJ; Department of Health Research Methods, Evidence & Impact, McMaster University, Ontario, Canada.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Michael G. DeGroote Cochrane Canada Centre & McMaster GRADE Centre, McMaster University, Hamilton, Ontario, Canada., Dahm P; Minneapolis VA Healthcare System, Minneapolis, Minnesota.; Department of Urology, University of Minnesota School of Medicine, Minneapolis, Minnesota.

المصدر: The Journal of urology [J Urol] 2023 Sep; Vol. 210 (3), pp. 529-536. Date of Electronic Publication: 2023 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Checklist*, Humans ; Europe ; Systematic Reviews as Topic ; Urology

المؤلفون: Kang M; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Park JY; Department of Urology, Korea University College of Medicine, Seoul, Republic of Korea., Jeong CW; Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea., Hwang EC; Department of Urology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea., Song C; Department of Urology, Asan Medical Center, Seoul, Republic of Korea., Hong SH; Department of Urology, Seoul St. Mary's Hospital, Seoul, Republic of Korea., Kwak C; Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea., Chung J; Department of Urology, National Cancer Center, Goyang, Republic of Korea., Sung HH; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Jeon HG; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea., Park SH; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee HM; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Choi HY; Department of Urology, Kangbuk Samsung Hospital, Seoul, Republic of Korea., Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: siseo@skku.edu.

المصدر: The Journal of urology [J Urol] 2018 Nov; Vol. 200 (5), pp. 989-995. Date of Electronic Publication: 2018 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell/*drug therapy , Carcinoma, Renal Cell/*mortality , Kidney Neoplasms/*drug therapy , Kidney Neoplasms/*mortality , Molecular Targeted Therapy/*methods , Protein Kinase Inhibitors/*therapeutic use, Adult ; Aged ; Carcinoma, Renal Cell/pathology ; Cause of Death ; Cohort Studies ; Databases, Factual ; Female ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Metastasis ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Retrospective Studies ; Risk Assessment ; Survival Analysis ; Time Factors